• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Heska Corporation Announces Acquisition of CVM Companies

Share:

January 13, 2020

Heska Corporation (NASDAQ: HSKA – News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty products, announced today that the Company has acquired a 100% interest in CVM Diagnostico Veterinario, S.L. and CVM Ecografía, S.L. (referred to collectively as the “CVM Companies” or “CVM”) of Spain. The CVM Companies have been leading providers for over 25 years of imaging and blood testing products to the companion animal market in Spain, a market with approximately 6,000 veterinary clinics and hospitals. CVM Companies estimate their market share prior to the deal at #1 in Ultrasound, #1 in Digital Radiography, and #2 in POC Blood Diagnostics.

Heska’s Chief Executive Officer and President, Kevin Wilson, commented, “We have respected the reputation the CVM Companies have built in Spain for some time. We are pleased they agreed late last year to join the Heska family. Adding a strong presence in Spain is consistent with our stated strategy of expanding Heska’s presence in the companion animal diagnostic market throughout the globe. With over 2,500 active customers of advanced veterinary diagnostics that are supported by a highly trained support team and substantial logistics assets, CVM is exactly what we were looking for to expand Heska into Spain. The Spanish market is a healthy, core European market that fits well with Heska’s Reset subscriptions model for diagnostics and it is a key part of Heska’s geographic expansion strategy in advance of our upcoming product launches. We are thrilled to make this investment in CVM and their strong, experienced team to grow together in our quest to be #1 or #2 in the markets we serve.”

CVM Companies’ co-founders, Roberto Rupérez Crespo, DVM, and Carlos Rupérez Crespo, DVM, jointly added, “We are proud of the healthy and growing business the entire CVM team has built over this past 25 years. We have partnered with our veterinarian friends and associates throughout Spain in ultrasound, digital radiography, point of care laboratory, education, MRI, and other technologies for over two decades. With this new chapter, we prepare to invest and grow even faster. While we don’t expect major near term changes in our business as a result of this agreement, we are excited by the products Heska has now and under development that will be of strong interest to thousands of CVM veterinarian customers throughout Spain and into broader Europe. Products such as Heska’s Element i+ (immunoassay) and upcoming Element UF (urine-fecal) analyzer offer more advanced methods and exclusive tests to address patient and veterinarian needs. We are confident that CVM is the team to bring them to the Spanish market as the winning solutions. The whole CVM team is excited about this next chapter together with Heska.”

Source: Prnews Wire

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Regulators Force Medical Device Manufacturers to Protect Against CyberattacksRegulators Force Medical Device Manufacturers to Protect Against Cyberattacks
  • Alamar Biosciences: $128M Boost for Precision ProteomicsAlamar Biosciences: $128M Boost for Precision Proteomics
  • Pediatric Biofeedback Video Game Maker Mightier Lands Additional $250,000Pediatric Biofeedback Video Game Maker Mightier Lands Additional $250,000
  • BioVaxys in Non-Binding Discussions for Major Immuno therapeutics Technology AcquisitionBioVaxys in Non-Binding Discussions for Major Immuno therapeutics Technology Acquisition
  • PKG Inc.’s CEO Excited With the Potential Acquisition by Cerebain BiotechPKG Inc.’s CEO Excited With the Potential Acquisition by Cerebain Biotech
  • Medisca Acquires all IP Assets of Maxima Pharmaceuticals Including the DIFFUSIMAX® BrandMedisca Acquires all IP Assets of Maxima Pharmaceuticals Including the DIFFUSIMAX® Brand
  • Talking About Cybersecurity Vulnerabilities in Medical Devices Shouldn’t be TabooTalking About Cybersecurity Vulnerabilities in Medical Devices Shouldn’t be Taboo
  • Medtronic Secures 2 CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin PenMedtronic Secures 2 CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications